4 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 4 of 4 clinical reviews.
Evidence review of insulin degludec (Tresiba) efficacy differences in Black and African ancestry populations, covering trial representation, HbA1c discordance, pharmacogenomic factors, and dosing considerations.
Evidence-based review of insulin degludec (Tresiba) safety considerations for Black and African ancestry patients, including pharmacogenomic factors, cardiovascular outcomes from DEVOTE, and clinical monitoring recommendations.
Ethnicity-stratified trial data, pharmacogenomic evidence, and clinical dosing guidance for insulin degludec (Tresiba) in East Asian patients with type 1 and type 2 diabetes.
A detailed clinical review of insulin degludec (Tresiba) safety, pharmacokinetics, and dosing in South Asian patients, including ethnicity-stratified trial data, hypoglycemia risk, and cardiovascular considerations.